Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiongju Shangqing Wan is a Traditional Chinese Medicine (TCM) product marketed under the Gaitianli brand by Xiuzheng Pharmaceutical Group. It is an over-the-counter (OTC) herbal formulation indicated for the relief of symptoms associated with wind-heat patterns, including headaches, dizziness, nasal congestion, and sore throat. The preparation typically consists of several herbal ingredients such as *Ligusticum chuanxiong*, *Chrysanthemum morifolium*, *Scutellaria baicalensis*, and *Mentha canadensis*. These components are traditionally recognized for their ability to clear heat, dispel wind, and provide analgesic effects. As a marketed product in China, it is widely used for upper respiratory discomfort and tension-type or migraine-like headaches attributed to heat syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiongju shangqing wan.